Although it is evident that many concepts need still to be defined, such as the maximum response to irisin or the existence of a potential irisin resistance, similar to what is being discussed for resistance to leptin, increasing irisin production can be a promising avenue for the prevention and treatment of obesity, and accordingly of NAFLD. The gene discussed is LEP; the disease is obesity disorder.